Division of Hematology, University of British Columbia, Vancouver, BC V5Z1M9, Canada.
Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC V6T1Z3, Canada.
Cell Rep Med. 2021 May 18;2(5):100269. doi: 10.1016/j.xcrm.2021.100269. Epub 2021 Apr 19.
Data suggest that interleukin (IL)-6 blockade could reduce mortality in severe COVID-19, yet IL-6 is only modestly elevated in most patients. Chen et al. describe the role of soluble interleukin-6 receptor (sIL-6R) in IL-6 -signaling and how understanding the IL-6:sIL-6R axis might help define and treat COVID-19 cytokine storm syndrome.
数据表明,白细胞介素 (IL)-6 阻断可能降低重症 COVID-19 的死亡率,但大多数患者的 IL-6 水平仅略有升高。Chen 等人描述了可溶性白细胞介素-6 受体 (sIL-6R) 在 IL-6 信号传导中的作用,以及了解 IL-6:sIL-6R 轴如何帮助定义和治疗 COVID-19 细胞因子风暴综合征。